DOLPHIN HOUSE SURGERY — All Prescriptions & Medications
Practice Code: E82092 | WARE, SG12 9HJ
Over the last 12 months, DOLPHIN HOUSE SURGERY prescribed 325,976 items across 725 different medications at a total cost of £2,528,086 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Captopril | 10 | 280 | £42 | -30.9% ▼ |
| Flupentixol decanoate | 10 | 20 | £49 | -37.3% ▼ |
| Dosulepin hydrochloride | 10 | 257 | £47 | -82.3% ▼ |
| Oestrogens conjugated with progestogen | 10 | 1,680 | £649 | +40.3% ▲ |
| Metronidazole | 10 | 400 | £41 | +51.2% ▲ |
| Lidocaine | 10 | 300 | £34 | +111.3% ▲ |
| Fludroxycortide | 10 | 11 | £245 | -5.2% ▼ |
| Clindamycin phosphate | 10 | 300 | £62 | -39.2% ▼ |
| 10 | 88 | £325 | +12.4% ▲ | |
| 10 | 10 | £410 | +148.3% ▲ | |
| 10 | 38 | £1.0K | -2.0% ▼ | |
| 10 | 20 | £368 | +120.7% ▲ | |
| 10 | 85 | £175 | -15.2% ▼ | |
| 10 | 1,000 | £200 | -61.2% ▼ | |
| 10 | 570 | £1.6K | -32.4% ▼ | |
| 10 | 300 | £1.6K | -55.2% ▼ | |
| 10 | 100 | £145 | +8.6% ▲ | |
| 10 | 100 | £396 | +49.1% ▲ | |
| Daridorexant | 11 | 330 | £439 | -15.8% ▼ |
| Rufinamide | 11 | 25.3K | £4.9K | -35.9% ▼ |
| Rifaximin | 11 | 392 | £1.8K | -59.0% ▼ |
| Propylthiouracil | 11 | 324 | £34 | -12.5% ▼ |
| Somatropin | 11 | 51 | £7.2K | -22.4% ▼ |
| Norethisterone | 11 | 2,156 | £52 | -21.3% ▼ |
| Levonorgestrel | 11 | 13 | £41 | +172.9% ▲ |
| Sirolimus | 11 | 330 | £952 | -7.0% ▼ |
| Sodium chloride | 11 | 712 | £66 | -53.5% ▼ |
| Other phosphate supplement preparations | 11 | 880 | £167 | +80.3% ▲ |
| Heparinoid | 11 | 1,375 | £75 | -58.1% ▼ |
| Tafluprost and timolol | 11 | 330 | £160 | -42.7% ▼ |
| Hydrocortisone acetate | 11 | 110 | £348 | +66.4% ▲ |
| Hydrocortisone | 11 | 110 | £78 | +323.6% ▲ |
| Azelastine hydrochloride | 11 | 240 | £109 | -1.9% vs avg |
| Triamcinolone acetonide | 11 | 11 | £77 | +7.4% ▲ |
| Hydrocortisone butyrate | 11 | 1,100 | £57 | +66.1% ▲ |
| 11 | 115 | £292 | +74.9% ▲ | |
| 11 | 110 | £156 | +67.9% ▲ | |
| 11 | 850 | £127 | -72.0% ▼ | |
| 11 | 320 | £1.9K | -4.4% ▼ | |
| Naloxegol | 12 | 360 | £629 | -13.0% ▼ |
| Nebivolol | 12 | 434 | £50 | -88.7% ▼ |
| Methyldopa | 12 | 672 | £141 | -29.5% ▼ |
| Olmesartan medoxomil/hydrochlorothiazide | 12 | 336 | £148 | +21.0% ▲ |
| Roflumilast | 12 | 360 | £430 | -8.6% ▼ |
| Lurasidone | 12 | 336 | £912 | -51.9% ▼ |
| Fluvoxamine maleate | 12 | 1,684 | £457 | -1.3% vs avg |
| Hyoscine hydrobromide | 12 | 340 | £58 | -64.9% ▼ |
| Valproic acid | 12 | 360 | £64 | -18.0% ▼ |
| Acarbose | 12 | 1,548 | £504 | +2.8% ▲ |
| Exenatide | 12 | 48 | £880 | -31.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.